Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial
Dietary fiber has recently received recognition for reducing the risk of developing diabetes and heart disease. The implication is that it may have therapeutic benefit in prediabetic metabolic conditions. To test this hypothesis, we investigated the effect of supplementing a high-carbohydrate diet w...
Gespeichert in:
| Veröffentlicht in: | Diabetes care 2000-01, Vol.23 (1), p.9-14 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 14 |
|---|---|
| container_issue | 1 |
| container_start_page | 9 |
| container_title | Diabetes care |
| container_volume | 23 |
| creator | Vuksan, V Sievenpiper, J L Owen, R Swilley, J A Spadafora, P Jenkins, D J Vidgen, E Brighenti, F Josse, R G Leiter, L A Xu, Z Novokmet, R |
| description | Dietary fiber has recently received recognition for reducing the risk of developing diabetes and heart disease. The implication is that it may have therapeutic benefit in prediabetic metabolic conditions. To test this hypothesis, we investigated the effect of supplementing a high-carbohydrate diet with fiber from Konjac-mannan (KJM) on metabolic control in subjects with the insulin resistance syndrome.
We screened 278 free-living subjects between the ages of 45 and 65 years from the Canadian-Maltese Diabetes Study. A total of 11 (age 55+/-4 years, BMI 28+/-1.5 kg/m2) were recruited who satisfied the inclusion criteria: impaired glucose tolerance, reduced HDL cholesterol, elevated serum triglycerides, and moderate hypertension. After an 8-week baseline, they were randomly assigned to take either KJM fiber-enriched test biscuits (0.5 g of glucomannan per 100 kcal of dietary intake or 8-13 g/day) or wheat bran fiber (WB) control biscuits for two 3-week treatment periods separated by a 2-week washout. The diets were isoenergetic, metabolically controlled, and conformed to National Cholesterol Education Program Step 2 guidelines. Serum lipids, glycemic control, and blood pressure were the outcome measures.
Decreases in serum cholesterol (total, 12.4+/-3.1%, P |
| doi_str_mv | 10.2337/diacare.23.1.9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71192114</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71192114</sourcerecordid><originalsourceid>FETCH-LOGICAL-c358t-a7106094fc13f29ff46259f83e3a35d7b76e72ddda532cf53f7d1765558b6cb73</originalsourceid><addsrcrecordid>eNpdkU2PFCEQhonRuLOrV4-GePDWIx9N03jTja7GTbzomdBQZJnQsAKt2X_iz5Vx5mA8kap63qqiXoReULJnnMs3LhhrCvRgT_fqEdpRxcUgxDg_RjtCRzUIpdgFuqz1QAgZx3l-ii4omYVUE9mh3-8hgQ82mIjBe7Ct4uzxz1Bt3ip2AZopD9iHBQr2Ja_4S04HY4fVpGQSDgnXbTn81f0K7Q63O-jJusVeKVBDbSZZwPUhua6Gt8fkFk9TDLY5tZJjBIfXPmnJMVjcSt_mGXriTazw_Pxeoe8fP3y7_jTcfr35fP3udrBczG0wkpKJqNFbyj1T3o8TE8rPHLjhwslFTiCZc84IzqwX3EtH5SSEmJfJLpJfodenvvcl_9igNr32v0OMJkG_gJaUKkbp2MFX_4GHvJXUd9OMcSLYSFSH9ifIllxrAa_vS1j7BTUl-miYPhvWA031UfDy3HVbVnD_4CeH-B_MSZXM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223052409</pqid></control><display><type>article</type><title>Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Vuksan, V ; Sievenpiper, J L ; Owen, R ; Swilley, J A ; Spadafora, P ; Jenkins, D J ; Vidgen, E ; Brighenti, F ; Josse, R G ; Leiter, L A ; Xu, Z ; Novokmet, R</creator><creatorcontrib>Vuksan, V ; Sievenpiper, J L ; Owen, R ; Swilley, J A ; Spadafora, P ; Jenkins, D J ; Vidgen, E ; Brighenti, F ; Josse, R G ; Leiter, L A ; Xu, Z ; Novokmet, R</creatorcontrib><description><![CDATA[Dietary fiber has recently received recognition for reducing the risk of developing diabetes and heart disease. The implication is that it may have therapeutic benefit in prediabetic metabolic conditions. To test this hypothesis, we investigated the effect of supplementing a high-carbohydrate diet with fiber from Konjac-mannan (KJM) on metabolic control in subjects with the insulin resistance syndrome.
We screened 278 free-living subjects between the ages of 45 and 65 years from the Canadian-Maltese Diabetes Study. A total of 11 (age 55+/-4 years, BMI 28+/-1.5 kg/m2) were recruited who satisfied the inclusion criteria: impaired glucose tolerance, reduced HDL cholesterol, elevated serum triglycerides, and moderate hypertension. After an 8-week baseline, they were randomly assigned to take either KJM fiber-enriched test biscuits (0.5 g of glucomannan per 100 kcal of dietary intake or 8-13 g/day) or wheat bran fiber (WB) control biscuits for two 3-week treatment periods separated by a 2-week washout. The diets were isoenergetic, metabolically controlled, and conformed to National Cholesterol Education Program Step 2 guidelines. Serum lipids, glycemic control, and blood pressure were the outcome measures.
Decreases in serum cholesterol (total, 12.4+/-3.1%, P<0.004; LDL, 22+/-3.9%, P<0.002; total/HDL ratio, 15.2+/-3.4%, P<0.003; and LDL/HDL ratio, 22.2+/-4.1%, P< 0.002), apolipoprotein (apo) B (15.1+/-4.3%, P<0.0004), apo B/A-1 ratio (13.1+/-3.4%, P< 0.0003), and serum fructosamine (5.2+/-1.4%, P<0.002) were observed during KJM treatment compared with WB-control. Fasting blood glucose, insulin, triglycerides, HDL cholesterol, and body weight remained unchanged.
A diet rich in high-viscosity KJM improves glycemic control and lipid profile, suggesting a therapeutic potential in the treatment of the insulin resistance syndrome.]]></description><identifier>ISSN: 0149-5992</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/diacare.23.1.9</identifier><identifier>PMID: 10857960</identifier><identifier>CODEN: DICAD2</identifier><language>eng</language><publisher>United States: American Diabetes Association</publisher><subject>Aged ; Blood Glucose - metabolism ; Cholesterol - blood ; Cholesterol, HDL - blood ; Cholesterol, LDL - blood ; Dietary Fiber - therapeutic use ; Double-Blind Method ; Glucose Intolerance - blood ; Glucose Intolerance - therapy ; Humans ; Insulin Resistance ; Mannans ; Middle Aged</subject><ispartof>Diabetes care, 2000-01, Vol.23 (1), p.9-14</ispartof><rights>Copyright American Diabetes Association Jan 2000</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c358t-a7106094fc13f29ff46259f83e3a35d7b76e72ddda532cf53f7d1765558b6cb73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27913,27914</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10857960$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vuksan, V</creatorcontrib><creatorcontrib>Sievenpiper, J L</creatorcontrib><creatorcontrib>Owen, R</creatorcontrib><creatorcontrib>Swilley, J A</creatorcontrib><creatorcontrib>Spadafora, P</creatorcontrib><creatorcontrib>Jenkins, D J</creatorcontrib><creatorcontrib>Vidgen, E</creatorcontrib><creatorcontrib>Brighenti, F</creatorcontrib><creatorcontrib>Josse, R G</creatorcontrib><creatorcontrib>Leiter, L A</creatorcontrib><creatorcontrib>Xu, Z</creatorcontrib><creatorcontrib>Novokmet, R</creatorcontrib><title>Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial</title><title>Diabetes care</title><addtitle>Diabetes Care</addtitle><description><![CDATA[Dietary fiber has recently received recognition for reducing the risk of developing diabetes and heart disease. The implication is that it may have therapeutic benefit in prediabetic metabolic conditions. To test this hypothesis, we investigated the effect of supplementing a high-carbohydrate diet with fiber from Konjac-mannan (KJM) on metabolic control in subjects with the insulin resistance syndrome.
We screened 278 free-living subjects between the ages of 45 and 65 years from the Canadian-Maltese Diabetes Study. A total of 11 (age 55+/-4 years, BMI 28+/-1.5 kg/m2) were recruited who satisfied the inclusion criteria: impaired glucose tolerance, reduced HDL cholesterol, elevated serum triglycerides, and moderate hypertension. After an 8-week baseline, they were randomly assigned to take either KJM fiber-enriched test biscuits (0.5 g of glucomannan per 100 kcal of dietary intake or 8-13 g/day) or wheat bran fiber (WB) control biscuits for two 3-week treatment periods separated by a 2-week washout. The diets were isoenergetic, metabolically controlled, and conformed to National Cholesterol Education Program Step 2 guidelines. Serum lipids, glycemic control, and blood pressure were the outcome measures.
Decreases in serum cholesterol (total, 12.4+/-3.1%, P<0.004; LDL, 22+/-3.9%, P<0.002; total/HDL ratio, 15.2+/-3.4%, P<0.003; and LDL/HDL ratio, 22.2+/-4.1%, P< 0.002), apolipoprotein (apo) B (15.1+/-4.3%, P<0.0004), apo B/A-1 ratio (13.1+/-3.4%, P< 0.0003), and serum fructosamine (5.2+/-1.4%, P<0.002) were observed during KJM treatment compared with WB-control. Fasting blood glucose, insulin, triglycerides, HDL cholesterol, and body weight remained unchanged.
A diet rich in high-viscosity KJM improves glycemic control and lipid profile, suggesting a therapeutic potential in the treatment of the insulin resistance syndrome.]]></description><subject>Aged</subject><subject>Blood Glucose - metabolism</subject><subject>Cholesterol - blood</subject><subject>Cholesterol, HDL - blood</subject><subject>Cholesterol, LDL - blood</subject><subject>Dietary Fiber - therapeutic use</subject><subject>Double-Blind Method</subject><subject>Glucose Intolerance - blood</subject><subject>Glucose Intolerance - therapy</subject><subject>Humans</subject><subject>Insulin Resistance</subject><subject>Mannans</subject><subject>Middle Aged</subject><issn>0149-5992</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkU2PFCEQhonRuLOrV4-GePDWIx9N03jTja7GTbzomdBQZJnQsAKt2X_iz5Vx5mA8kap63qqiXoReULJnnMs3LhhrCvRgT_fqEdpRxcUgxDg_RjtCRzUIpdgFuqz1QAgZx3l-ii4omYVUE9mh3-8hgQ82mIjBe7Ct4uzxz1Bt3ip2AZopD9iHBQr2Ja_4S04HY4fVpGQSDgnXbTn81f0K7Q63O-jJusVeKVBDbSZZwPUhua6Gt8fkFk9TDLY5tZJjBIfXPmnJMVjcSt_mGXriTazw_Pxeoe8fP3y7_jTcfr35fP3udrBczG0wkpKJqNFbyj1T3o8TE8rPHLjhwslFTiCZc84IzqwX3EtH5SSEmJfJLpJfodenvvcl_9igNr32v0OMJkG_gJaUKkbp2MFX_4GHvJXUd9OMcSLYSFSH9ifIllxrAa_vS1j7BTUl-miYPhvWA031UfDy3HVbVnD_4CeH-B_MSZXM</recordid><startdate>200001</startdate><enddate>200001</enddate><creator>Vuksan, V</creator><creator>Sievenpiper, J L</creator><creator>Owen, R</creator><creator>Swilley, J A</creator><creator>Spadafora, P</creator><creator>Jenkins, D J</creator><creator>Vidgen, E</creator><creator>Brighenti, F</creator><creator>Josse, R G</creator><creator>Leiter, L A</creator><creator>Xu, Z</creator><creator>Novokmet, R</creator><general>American Diabetes Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0K</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>200001</creationdate><title>Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial</title><author>Vuksan, V ; Sievenpiper, J L ; Owen, R ; Swilley, J A ; Spadafora, P ; Jenkins, D J ; Vidgen, E ; Brighenti, F ; Josse, R G ; Leiter, L A ; Xu, Z ; Novokmet, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c358t-a7106094fc13f29ff46259f83e3a35d7b76e72ddda532cf53f7d1765558b6cb73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Aged</topic><topic>Blood Glucose - metabolism</topic><topic>Cholesterol - blood</topic><topic>Cholesterol, HDL - blood</topic><topic>Cholesterol, LDL - blood</topic><topic>Dietary Fiber - therapeutic use</topic><topic>Double-Blind Method</topic><topic>Glucose Intolerance - blood</topic><topic>Glucose Intolerance - therapy</topic><topic>Humans</topic><topic>Insulin Resistance</topic><topic>Mannans</topic><topic>Middle Aged</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vuksan, V</creatorcontrib><creatorcontrib>Sievenpiper, J L</creatorcontrib><creatorcontrib>Owen, R</creatorcontrib><creatorcontrib>Swilley, J A</creatorcontrib><creatorcontrib>Spadafora, P</creatorcontrib><creatorcontrib>Jenkins, D J</creatorcontrib><creatorcontrib>Vidgen, E</creatorcontrib><creatorcontrib>Brighenti, F</creatorcontrib><creatorcontrib>Josse, R G</creatorcontrib><creatorcontrib>Leiter, L A</creatorcontrib><creatorcontrib>Xu, Z</creatorcontrib><creatorcontrib>Novokmet, R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Agricultural Science Database</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database (ProQuest)</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vuksan, V</au><au>Sievenpiper, J L</au><au>Owen, R</au><au>Swilley, J A</au><au>Spadafora, P</au><au>Jenkins, D J</au><au>Vidgen, E</au><au>Brighenti, F</au><au>Josse, R G</au><au>Leiter, L A</au><au>Xu, Z</au><au>Novokmet, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial</atitle><jtitle>Diabetes care</jtitle><addtitle>Diabetes Care</addtitle><date>2000-01</date><risdate>2000</risdate><volume>23</volume><issue>1</issue><spage>9</spage><epage>14</epage><pages>9-14</pages><issn>0149-5992</issn><eissn>1935-5548</eissn><coden>DICAD2</coden><abstract><![CDATA[Dietary fiber has recently received recognition for reducing the risk of developing diabetes and heart disease. The implication is that it may have therapeutic benefit in prediabetic metabolic conditions. To test this hypothesis, we investigated the effect of supplementing a high-carbohydrate diet with fiber from Konjac-mannan (KJM) on metabolic control in subjects with the insulin resistance syndrome.
We screened 278 free-living subjects between the ages of 45 and 65 years from the Canadian-Maltese Diabetes Study. A total of 11 (age 55+/-4 years, BMI 28+/-1.5 kg/m2) were recruited who satisfied the inclusion criteria: impaired glucose tolerance, reduced HDL cholesterol, elevated serum triglycerides, and moderate hypertension. After an 8-week baseline, they were randomly assigned to take either KJM fiber-enriched test biscuits (0.5 g of glucomannan per 100 kcal of dietary intake or 8-13 g/day) or wheat bran fiber (WB) control biscuits for two 3-week treatment periods separated by a 2-week washout. The diets were isoenergetic, metabolically controlled, and conformed to National Cholesterol Education Program Step 2 guidelines. Serum lipids, glycemic control, and blood pressure were the outcome measures.
Decreases in serum cholesterol (total, 12.4+/-3.1%, P<0.004; LDL, 22+/-3.9%, P<0.002; total/HDL ratio, 15.2+/-3.4%, P<0.003; and LDL/HDL ratio, 22.2+/-4.1%, P< 0.002), apolipoprotein (apo) B (15.1+/-4.3%, P<0.0004), apo B/A-1 ratio (13.1+/-3.4%, P< 0.0003), and serum fructosamine (5.2+/-1.4%, P<0.002) were observed during KJM treatment compared with WB-control. Fasting blood glucose, insulin, triglycerides, HDL cholesterol, and body weight remained unchanged.
A diet rich in high-viscosity KJM improves glycemic control and lipid profile, suggesting a therapeutic potential in the treatment of the insulin resistance syndrome.]]></abstract><cop>United States</cop><pub>American Diabetes Association</pub><pmid>10857960</pmid><doi>10.2337/diacare.23.1.9</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0149-5992 |
| ispartof | Diabetes care, 2000-01, Vol.23 (1), p.9-14 |
| issn | 0149-5992 1935-5548 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71192114 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Aged Blood Glucose - metabolism Cholesterol - blood Cholesterol, HDL - blood Cholesterol, LDL - blood Dietary Fiber - therapeutic use Double-Blind Method Glucose Intolerance - blood Glucose Intolerance - therapy Humans Insulin Resistance Mannans Middle Aged |
| title | Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T08%3A39%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Beneficial%20effects%20of%20viscous%20dietary%20fiber%20from%20Konjac-mannan%20in%20subjects%20with%20the%20insulin%20resistance%20syndrome:%20results%20of%20a%20controlled%20metabolic%20trial&rft.jtitle=Diabetes%20care&rft.au=Vuksan,%20V&rft.date=2000-01&rft.volume=23&rft.issue=1&rft.spage=9&rft.epage=14&rft.pages=9-14&rft.issn=0149-5992&rft.eissn=1935-5548&rft.coden=DICAD2&rft_id=info:doi/10.2337/diacare.23.1.9&rft_dat=%3Cproquest_cross%3E71192114%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223052409&rft_id=info:pmid/10857960&rfr_iscdi=true |